Q-Bank Breakdown: Cardiac output determinants — Why Every Answer Choice Matters

Cardiac output (CO) questions are sneaky because they rarely ask “What is CO?”—they ask you to reason through what happens to preload, afterload, contractility, heart rate, and venous return in a real patient. The fastest way to stop missing these is to treat every answer choice like it’s trying to teach you physiology, not just trick you.

---

The Core Framework (what you should hear in your head)

Cardiac output:

• $CO = HR \times SV$

Stroke volume (SV) is mainly determined by:

• Preload (LV end-diastolic volume/pressure; venous return)
• Afterload (LV wall stress; approximated by MAP/SVR)
• Contractility (inotropy; Ca$^{2+}$ handling; sympathetic tone)

If you can map a vignette to which of these changed, you can usually kill the question quickly.

---

Clinical Vignette (Q-bank style)

A 67-year-old man with a history of long-standing hypertension presents with acute dyspnea and pink frothy sputum. BP is 190/110 mm Hg, HR 110/min, RR 28/min, O$_2$ sat 88% on room air. Exam shows diffuse crackles and an S3. CXR demonstrates pulmonary edema. He is started on an IV infusion of sodium nitroprusside.

Which of the following is the primary mechanism by which this medication increases cardiac output?

A. Increased venous return due to venoconstriction
B. Decreased afterload due to arteriolar dilation
C. Increased contractility via $\beta_1$ stimulation
D. Increased preload due to increased LV end-diastolic volume
E. Decreased heart rate due to enhanced vagal tone

---

Step-by-Step: What’s happening in this patient?

This is acute decompensated heart failure with pulmonary edema, driven in part by markedly elevated afterload (severe hypertension). In LV systolic dysfunction, a sudden afterload increase makes it harder for the LV to eject → SV drops → CO drops, while LV end-diastolic pressure backs up into the lungs → edema.

Nitroprusside is a “clean” hemodynamics drug:

• Arterial dilation → ↓ afterload
• Venous dilation → ↓ preload
• Net effect in acute HF with high SVR: SV increases because lowering afterload improves forward flow.

---

Correct Answer: B. Decreased afterload due to arteriolar dilation

Why this is correct

In systolic HF, the LV is weak; it benefits tremendously from reducing the resistance it pumps against.

High-yield physiology:

• Afterload goes down → ejection fraction rises (in systolic dysfunction)
• SV rises → CO rises (even if HR stays the same)
• Lower LV end-systolic volume often improves subsequent filling dynamics too

Nitroprusside mechanism: releases nitric oxide (NO) → ↑ cGMP → smooth muscle relaxation → balanced vasodilation, with strong clinical utility for hypertensive emergency + acute pulmonary edema.

---

Why Every Distractor Is Wrong (and what it’s trying to teach you)

A. Increased venous return due to venoconstriction

Wrong because nitroprusside does the opposite: venodilation.

High-yield tie-in:

• Venodilation → ↓ venous return → ↓ preload
• That’s helpful for pulmonary edema (less pulmonary capillary hydrostatic pressure)

If the question wanted venoconstriction increasing venous return, think:

• Sympathetic $\alpha_1$ activation
• Volume loss compensation (e.g., hemorrhage → vasoconstriction)

---

C. Increased contractility via $\beta_1$ stimulation

Wrong because nitroprusside is not an inotrope.

If you want to increase contractility:

• Dobutamine ($\beta_1$ agonist) → ↑ cAMP → ↑ Ca$^{2+}$ → ↑ inotropy
• Milrinone (PDE-3 inhibitor) → ↑ cAMP in heart & vessels → ↑ inotropy + vasodilation

Clinical nuance:

• In acute decompensated HF, you choose inotropes when there’s poor perfusion/cardiogenic shock (cold, clammy, hypotensive), not primarily when the issue is excess afterload with hypertension.

---

D. Increased preload due to increased LV end-diastolic volume

Wrong because nitroprusside reduces preload (via venodilation).

Key concept: Frank–Starling has limits

• Increasing preload can increase SV only up to a point
• In systolic HF, pushing preload often just worsens congestion (pulmonary edema) with minimal CO gain

When does increased preload help?

• Hypovolemia (e.g., hemorrhage, dehydration) → fluids increase preload → SV increases

---

E. Decreased heart rate due to enhanced vagal tone

Wrong because nitroprusside may cause reflex tachycardia, not bradycardia.

High-yield autonomic physiology:

• Vasodilation → ↓ MAP → baroreceptor firing decreases → ↑ sympathetic tone
• Result: ↑ HR and ↑ contractility reflexively (unless blunted by beta-blockers)

If the vignette wanted vagal-mediated bradycardia:

• Carotid sinus massage, phenylephrine-induced reflex bradycardia (via ↑ MAP → ↑ baroreceptor firing)

---

The High-Yield Hemodynamics Table (memorize the patterns)

---

Rapid-Fire USMLE Pearls (CO determinants you’ll see again)

• CO = HR × SV; don’t forget HR can be the primary driver in arrhythmias.
• MAP ≈ CO × SVR (clinically helpful for reasoning through reflexes).
• Afterload approximations: SVR/MAP; increased by vasoconstriction, HTN, aortic stenosis.
• Preload approximations: venous return, EDV, PCWP (left-sided filling pressures).
• S3 = increased ventricular filling volume/pressure (classically systolic HF, dilated ventricle).
• Nitroprusside: balanced vasodilator → ↓ afterload + ↓ preload; watch for cyanide toxicity (especially prolonged infusion, renal dysfunction).

---

How to Answer These Fast on Test Day

1. Translate the vignette into the limiting problem (here: excess afterload + LV failure).
2. Decide which lever best improves forward flow (here: decrease afterload).
3. Use distractors as “physiology flags”:
   • Venoconstriction? Preload up.
   • $\beta_1$? Inotropy/HR up.
   • Vagal tone? HR down.
   • Increased EDV? Preload up—helpful only if you’re on the ascending limb of Frank–Starling.

If you do that consistently, “CO determinants” stops being a memorization topic and becomes a logic game you can win.